US2010305323A1PendingUtilityA1
Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
Est. expiryMar 29, 2027(~0.7 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 39/02A61P 25/04A61P 17/04A61P 1/08A61P 17/00A61P 1/00A61P 1/10A61P 1/14A61P 13/02A61K 31/485C07D 489/08C07D 491/08C07D 489/04
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a new forms of (R)—N-methylnaltrexone, and compositions thereof, useful as a peripheral mu opioid receptor antagonist.
Claims
exact text as granted — not AI-modified1 - 51 . (canceled)
52 . Substantially pure amorphous Compound 1:
where the compound is in the (R) configuration with respect to the nitrogen.Join the waitlist — get patent alerts
Track US2010305323A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.